Emma Rossi

3.0k total citations · 1 hit paper
47 papers, 2.0k citations indexed

About

Emma Rossi is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Emma Rossi has authored 47 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Obstetrics and Gynecology, 21 papers in Reproductive Medicine and 10 papers in Surgery. Recurrent topics in Emma Rossi's work include Endometrial and Cervical Cancer Treatments (27 papers), Ovarian cancer diagnosis and treatment (19 papers) and Cervical Cancer and HPV Research (9 papers). Emma Rossi is often cited by papers focused on Endometrial and Cervical Cancer Treatments (27 papers), Ovarian cancer diagnosis and treatment (19 papers) and Cervical Cancer and HPV Research (9 papers). Emma Rossi collaborates with scholars based in United States, Australia and Canada. Emma Rossi's co-authors include John F. Boggess, Anastasia Ivanova, Rabbie K. Hanna, Leigh A. Cantrell, Lynn D. Kowalski, Kevin Schuler, Jennifer Scalici, Edward J. Tanner, Robert W. Holloway and Nadeem R. Abu‐Rustum and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and The Lancet Oncology.

In The Last Decade

Emma Rossi

40 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study

2017 599 citations Emma Rossi, Lynn D. Kowalski et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Emma Rossi

Since Specialization

Citations

This map shows the geographic impact of Emma Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Rossi more than expected).

Fields of papers citing papers by Emma Rossi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Rossi. The network helps show where Emma Rossi may publish in the future.

Co-authorship network of co-authors of Emma Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Rossi. A scholar is included among the top collaborators of Emma Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Rossi. Emma Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost-effectiveness of biomarker-based and universal strategies for the treatment of advanced-stage endometrial cancer 2025 ·Gynecologic Oncology ·(unknown), Ling Chen, (unknown), Elena B. Elkin, (unknown), Xiao Xu, Nina A. Bickell, Stephanie V. Blank, Emma Rossi, William D. Hazelton, Jason D. Wright, Laura J. Havrilesky, Evan R. Myers	0
2	Robotic sentinel lymph node mapping with sensitive Firefly for endometrial cancer staging 2024 ·International Journal of Gynecological Cancer ·(unknown), (unknown), Emma Rossi	0
3	The doc versus the bot: A pilot study to assess the quality and accuracy of physician and chatbot responses to clinical questions in gynecologic oncology 2024 ·Gynecologic Oncology Reports ·(unknown), (unknown), (unknown), Alexander Melamed, Susan C. Modesitt, Fernanda Musa, Emma Rossi, Benjamin B. Albright, Laura J. Havrilesky, Haley Moss	2
4	Delayed publication of clinical trials in gynecologic oncology 2024 ·Gynecologic Oncology ·(unknown), Emma Rossi, (unknown), Yingao Zhang, (unknown)	0
5	When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations During the COVID-19 Pandemic 2021 ·Obstetrical & Gynecological Survey ·Amanda N. Fader, Warner K. Huh, Joshua P. Kesterson, Bhavana Pothuri, Stephanie L. Wethington, Jason D. Wright, Jamie N. Bakkum‐Gamez, Pamela T. Soliman, Abdulrahman Sinno, Mario M. Leitão, Martin A Martino, Amer Karam, Emma Rossi, Jubilee Brown, Stephanie V. Blank, William M. Burke, Barbara A. Goff, Satoru Yamada, Shitanshu Uppal, Sean C. Dowdy	3
6	Genomic profiling of endometrial cancer and relationship with volume of endometrial cancer disease spread 2021 ·Gynecologic Oncology Reports ·Stephanie A. Sullivan, (unknown), (unknown), Heejoon Jo, D. Neil Hayes, Xiaoyan Deng, Dipankar Bandyopadhyay, Victoria Bae‐Jump, Emma Rossi	0
7	Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics 2021 ·American Journal of Obstetrics and Gynecology ·(unknown), Maria C. Cusimano, (unknown), Soyoun Rachel Kim, Rouhi Fazelzad, Osvaldo Espin‐Garcia, Geneviève Bouchard‐Fortier, Emma Rossi, (unknown), Pamela T. Soliman, Jeffrey How, Walter H. Gotlieb, Robert W. Holloway, Manuel Maria Ianieri, Sílvia Cabrera, Yong Kuei Lim, Sarah Ferguson	47
8	Defining the learning curve for successful staging with sentinel lymph node biopsy for endometrial cancer among surgeons at an academic institution 2020 ·International Journal of Gynecological Cancer ·Katherine L. Tucker, (unknown), Paola A. Gehrig, John T. Soper, John F. Boggess, Anastasia Ivanova, Emma Rossi	16
9	Benign hysterectomy performed by gynecologic oncologists: Is selection bias altering our ability to measure surgical quality? 2018 ·Gynecologic Oncology ·Emma L. Barber, Emma Rossi, Amy L. Alexander, Karl Y. Bilimoria, Melissa A. Simon	10
10	Extent of lymphadenectomy and postoperative major complications among women with endometrial cancer treated with minimally invasive surgery 2018 ·American Journal of Obstetrics and Gynecology ·(unknown), Emma Rossi, Emma L. Barber	30
11	A Comparison of Sentinel Lymph Node Biopsy to Lymphadenectomy for Endometrial Cancer Staging (FIRES Trial): A Multicentre, Prospective, Cohort Study 2017 ·Obstetrical & Gynecological Survey ·Emma Rossi, Lynn D. Kowalski, Jennifer Scalici, Leigh A. Cantrell, Kevin Schuler, Rabbie K. Hanna, (unknown), (unknown), Anastasia Ivanova, John F. Boggess	24
12	A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study breakdown → 2017 ·The Lancet Oncology ·Emma Rossi, Lynn D. Kowalski, Jennifer Scalici, Leigh A. Cantrell, Kevin Schuler, Rabbie K. Hanna, (unknown), (unknown), Anastasia Ivanova, John F. Boggess	599
13	Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survival 2017 ·Gynecologic Oncology ·Emma L. Barber, Stacie B. Dusetzina, Karyn B. Stitzenberg, Emma Rossi, Paola A. Gehrig, John F. Boggess, Joanne M. Garrett	14
14	Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations 2017 ·Gynecologic Oncology ·Robert W. Holloway, Nadeem R. Abu‐Rustum, Floor Backes, John F. Boggess, Walter H. Gotlieb, William J. Lowery, Emma Rossi, Edward J. Tanner, Rebecca J. Wolsky	264
15	A Novel Monoclonal Antibody to Secreted Frizzled-Related Protein 2 Inhibits Tumor Growth 2013 ·Molecular Cancer Therapeutics ·(unknown), Emma Rossi, Russell J. Mumper, (unknown), Sharareh Siamakpour‐Reihani, Ping Ma, Eleanor Hilliard, (unknown), David Ketelsen, (unknown), Cam Patterson, Nancy Klauber‐DeMore	43
16	Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173 2012 ·Gynecologic Oncology ·Robert L. Coleman, (unknown), Charles F. Levenback, Michael A. Gold, Jeffrey M. Fowler, Patricia L. Judson, Maria C. Bell, Koen De Geest, Nick M. Spirtos, Ronald K. Potkul, Mario M. Leitão, Jamie N. Bakkum‐Gamez, Emma Rossi, Samuel S. Lentz, James J. Burke, (unknown), Cornelia L. Trimble	54
17	Cytokine use and survival in the first-line treatment of ovarian cancer: A Gynecologic Oncology Group Study 2012 ·Gynecologic Oncology ·Frederick B. Stehman, Mark F. Brady, J.T. Thigpen, Emma Rossi, Robert A. Burger	6
18	Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: A multi-site study performed at high volume cancer centers 2012 ·Gynecologic Oncology ·Amanda N. Fader, Leigh G. Seamon, Pedro F. Escobar, Heidi E. Frasure, L. Havrilesky, Kristine Zanotti, Angeles Alvarez Secord, John F. Boggess, David E. Cohn, Jeffrey M. Fowler, (unknown), Emma Rossi, Paola A. Gehrig	82
19	Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: A feasibility study 2011 ·Gynecologic Oncology ·Emma Rossi, Anastasia Ivanova, John F. Boggess	144
20	Keratinocyte cancer prevention with ACE inhibitors, angiotensin receptor blockers or their combination in renal transplant recipients 2010 ·Clinical Nephrology ·(unknown), M. Zanazzi, G.B. John Mancini, Emma Rossi, (unknown), (unknown), E. Bertoni, Marina I. Salvadori	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact